Pharma channel feed

FDA ap­proves J&J's rare dis­ease drug that's ex­pect­ed to com­pete with ar­genx and UCB

Last month
FDA+

Up­dat­ed: No­var­tis to buy Reg­u­lus Ther­a­peu­tics for up to $1.7B

Last month
Deals

GSK's sup­ply chain 're­set' af­ter Ha­le­on spin­off to ease tar­iff im­pact, CEO says

Last month
Manufacturing

Bridge­Bio’s At­tru­by out­per­forms sales ex­pec­ta­tions, shares rise

Last month

Pfiz­er CEO Bourla sug­gests phar­ma tar­iffs will fo­cus on US ad­ver­saries, not al­lies

Last month
China

Join us at 12 p.m. ET: How phar­ma is re­act­ing to ‘Lib­er­a­tion Day’

Last month
Editor's note

FDA ap­proves Abeona’s skin dis­ease cell ther­a­py

Last month
Cell/Gene Tx
FDA+

With a new CEO, oligonu­cleotide biotech Crey­on forges Eli Lil­ly part­ner­ship

Last month
Financing
Startups

Hims and No­vo Nordisk part­ner to of­fer dis­count­ed We­govy

Last month
Health Tech

As­traZeneca, No­var­tis ex­e­cute ‘US for US’ strat­e­gy as phar­ma tar­iffs near

Last month
China
Manufacturing

Pfiz­er launch­es a new wave of cost cuts, ex­pects $7.7B in to­tal sav­ings through 2027

Last month

As­traZeneca posts an­oth­er Truqap study fail, says Chi­na im­port tax could triple

Last month
China
Law

No­var­tis con­tin­ues earn­ings win­ning streak as it rais­es 2025 sales ex­pec­ta­tions

Last month
R&D

Vaxart says it can re­sume next-gen Covid work, will screen par­tic­i­pants for oral vac­cine tri­al

Last month
FDA+
Coronavirus

No­vavax re­sponds to FDA’s tri­al ask, with Covid vac­cine strain up­dates un­der scruti­ny

Last month
FDA+
Coronavirus

WuXi AppTec sees growth af­ter 2024 dip, plans ‘lean’ op­er­a­tions to tem­per ‘ex­ter­nal op­por­tu­ni­ties’

Last month
China
Manufacturing

Dai­ichi Sankyo says pro­duc­tion boost in US will help cush­ion tar­iff im­pact

Last month
Manufacturing

Mer­ck KGaA to buy rare can­cer biotech Spring­Works for $3.9B

Last month
Deals

Eu­ro­pean reg­u­la­tors rec­om­mend new drugs from Ver­tex, Am­gen and Jazz 

Last month
FDA+

France stops Val­neva's chikun­gun­ya vac­cine roll­out in over 65s af­ter safe­ty is­sue

Last month

GSK’s check­point block­er Jem­per­li cures bio­mark­er-dri­ven rec­tal can­cer

Last month
R&D

FDA chief Makary talks ex­pe­dit­ing drug ap­provals, RIFs and the abor­tion pill

Last month
R&D
FDA+

Ab­b­Vie com­mits $10B to ex­pand US foot­print with the threat of tar­iffs ahead

Last month
Manufacturing

Com­pound­ing phar­ma­cies dealt a blow in fight over end of semaglu­tide short­age

Last month
Law
Health Tech
First page Previous page 3456789 Next page Last page
A service from the Financial Times